Diagnostic value of CSF 14-3-3 detection in sporadic CJD diagnosis according to the age of the patient [4]

European Journal of Neurology

Volumn 13, Issue 4, 2006, Pages 427-428

  Peoc'h, K ^a   Delasnerie Laupretre N ^b   Beaudry, P ^a   Laplanche, J L ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

14 3 3 protein; Creutzfeldt Jakob disease; Dementia; Prion

Indexed keywords

PRION PROTEIN; PROTEIN 14 3 3;

APOPTOSIS; AUTOPSY; CENTRAL NERVOUS SYSTEM DISEASE; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DIAGNOSTIC VALUE; HUMAN; LETTER; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RARE DISEASE; SENSITIVITY AND SPECIFICITY;

14-3-3 PROTEINS; AGE FACTORS; AGED; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; ENCEPHALITIS; FALSE POSITIVE REACTIONS; HUMANS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 33646027013     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01180.x     Document Type: Letter

References (5)

1. Prusiner SB. Genetic and infectious prion diseases Archives of Neurology 1993 50 1129 1153
2. Aitken A Baxter H Dubois T et al. Specificity of 14-3-3 isoform dimer interactions and phosphorylation Biochemical Society Transactions 2002 30 351 360
3. Brandel JP. Clinical aspects of human spongiform encephalopathies, with the exception of iatrogenic forms Biomedicine and Pharmacotherapy 1999 53 14 18
4. Beaudry P Cohen P Brandel JP et al. 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Dementia and Geriatric Cognitive Disorders 1999 10 40 46
5. Peoc'h K Beaudry P Laupretre N et al. CSF detection of the 14-3-3 protein in unselected patients with dementia Neurology 2002 12 509 510